ATA Guidelines Tools

Adults with Differentiated THyroid Cancer - 2025 Update

American Thyroid Association Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/1540959

Contents of this Issue

Navigation

Page 6 of 49

7 Recommendation 5 ➤ When genomic testing is performed on tumor samples for clinical purposes, both somatic and germline genetic alterations can be detected. If a potentially clinically relevant germline cancer- predisposing variant is detected, evaluate patients and their family histories for clinical correlation, and consider referral for genetic counseling for possible germline testing. (C-M) Treatment Recommendation 6 ➤ Due to lower complication rates and improved outcomes on average associated with high volume thyroid surgeons (>25–50 thyroidectomies/year), patients with thyroid cancer should be offered referral to a high-volume surgeon, particularly for tumors requiring more extensive surgery. (S-M) Recommendation 7 A. Preoperative neck ultrasound to evaluate cervical lymph nodes in the central and lateral neck compartments as well as for gross extrathyroidal extension is recommended for all patients undergoing surgery for malignant cytologic or molecular findings. (S-M) B. Ultrasound-guided fine needle aspiration (FNA) of sonographically suspicious lymph nodes greater than 8–10 mm in the smallest diameter should be performed to confirm malignancy if this would change management. (S-M) C. The addition of FNA-Tg washout in the evaluation of suspicious cervical lymph nodes may be performed in select preoperative patients, but interpretation may be difficult in patients with an intact thyroid gland. (C-L)

Articles in this issue

Archives of this issue

view archives of ATA Guidelines Tools - Adults with Differentiated THyroid Cancer - 2025 Update